This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Aug 18;380(9842):627-9.

doi: 10.1016/S0140-6736(12)61261-6.

Azithromycin in bronchiectasis: when should it be used?

Robert Wilson¹, Athol U Wells

Affiliations

PMID: 22901872
DOI: 10.1016/S0140-6736(12)61261-6

Comment

Azithromycin in bronchiectasis: when should it be used?

Robert Wilson et al. Lancet. 2012.

. 2012 Aug 18;380(9842):627-9.

doi: 10.1016/S0140-6736(12)61261-6.

Authors

Robert Wilson¹, Athol U Wells

Affiliation

¹ Royal Brompton Hospital, London SW3 6NP, UK.

PMID: 22901872
DOI: 10.1016/S0140-6736(12)61261-6

No abstract available

PubMed Disclaimer

Comment on

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T. Wong C, et al. Lancet. 2012 Aug 18;380(9842):660-7. doi: 10.1016/S0140-6736(12)60953-2. Lancet. 2012. PMID: 22901887 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information